title: Imatinib mesylate causes hypopigmentation in the skin.
authors.forename: Kin Wah
authors.initials: KW
authors.lastname: Leong
authors.forename: Thoong Chow
authors.initials: TC
authors.lastname: Lee
authors.forename: Ai Sim
authors.initials: AS
authors.lastname: Goh
mesh_terms: D001549:Benzamides; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced* / Q000503:physiopathology; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D020929:Mitogen-Activated Protein Kinase Kinases / Q000494:pharmacology; D010766:Phosphorylation; D010879:Piperazines / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D020929:Mitogen-Activated Protein Kinase Kinases